Fig. 2: Early antiviral treatment reduces the infectiousness of influenza virus.
From: Modeling mitigation of influenza epidemics by baloxavir
Reduction of infectiousness by treatment with a baloxavir or b oseltamivir compared with treatment with placebo. Patients were assumed to be treated within 48 h of symptom onset, with the same scheduling as in the clinical trial8. Lines and shading indicate medians and interquartile ranges across 1014 stochastic simulations, corresponding to the sample sizes of 427, 377, and 210 for the baloxavir, oseltamivir, and placebo clinical trial groups, respectively.
